LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $2,386,382

Key CONT_AWD_75N91023F00023_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 57 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91023F00023_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91023F00023_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:47Z

Content hash b602f8a52643bfeba7f26d8bfa0959659d36b2125c6283878c72945b64ade50d

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$2,386,382	first version	September 8, 2023	July 10, 2026	2026-09-05T00:55:47Z	historical sweep	`b602f8a52643`

Archived copy

https://web.archive.org/web/20261016005942/https://www.usaspending.gov/award/CONT_AWD_75N91023F00023_7529_75N91019D00024_7529 captured by this system, October 16, 2026

What the amount is made of

4 recorded actions, so the amount is the award's current total across all of them. 4 of them obligated money. Measured 2026-10-10, when USAspending reported a total obligation of $2,386,382.

Action date	Modification	Type	Obligated	Description as recorded
July 10, 2026	P00003	OTHER ADMINISTRATIVE ACTION	+$383,255	CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN
September 16, 2025	P00002	OTHER ADMINISTRATIVE ACTION	+$361,328	CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN
September 6, 2024	P00001	CHANGE ORDER	+$1,046,318	CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN
September 8, 2023	base	not on file	+$595,481	CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN

Last refreshed November 4, 2026 at 2:31 PM UTC.